(Q36273383)

13 August 2017

1 reference

title

Live bacterial cells as orally delivered therapeutics (English)

1 reference

13 August 2017

2

Jasmine Bhathena

1 reference

13 August 2017

Satya Prakash

1

1 reference

13 August 2017

language of work or name

English

0 references

publication date

1 October 2005

1 reference

Expert Opinion on Biological Therapy

13 August 2017

published in

1 reference

13 August 2017

volume

5

1 reference

13 August 2017

issue

10

1 reference

13 August 2017

page(s)

1281-1301

1 reference

Probiotics and human health: a clinical perspective

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.10.1281

Microbial-gut interactions in health and disease. Probiotics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.10.1281

Culture-independent analysis of probiotic products by denaturing gradient gel electrophoresis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.10.1281

Selection and design of probiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.10.1281

Probiotic spectra of lactic acid bacteria (LAB).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.10.1281

Probiotics: an overview of beneficial effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.10.1281

Summary of conclusions from a consensus panel of experts on health attributes of lactic cultures: significance to fluid milk products containing cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.10.1281

Effect of long term consumption of probiotic milk on infections in children attending day care centres: double blind, randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.10.1281

The effect of consumption of milk fermented by Lactobacillus casei strain Shirota on the intestinal microflora and immune parameters in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.10.1281

Probiotics: towards demonstrating efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.10.1281

Probiotics in prevention of antibiotic associated diarrhoea: meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.10.1281

Meta-analysis: the effect of probiotic administration on antibiotic-associated diarrhoea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.10.1281

Probiotics in the treatment and prevention of acute infectious diarrhea in infants and children: a systematic review of published randomized, double-blind, placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.10.1281

Prophylactic Lactobacillus GG reduces antibiotic-associated diarrhea in children with respiratory infections: a randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.10.1281

Lactobacillus GG in the prevention of antibiotic-associated diarrhea in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.10.1281

Probiotics and gastrointestinal diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.10.1281

Probiotics, antibiotic-associated diarrhoea and Clostridium difficile diarrhoea in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.10.1281

Lactobacillus plantarum 299v for the treatment of recurrent Clostridium difficile-associated diarrhoea: a double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.10.1281

Bacteriotherapy with Lactobacillus reuteri in rotavirus gastroenteritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.10.1281

Management of acute diarrhoea with low osmolarity oral rehydration solutions and Lactobacillus strain GG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.10.1281

Probiotics in pediatric gastrointestinal disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.10.1281

A placebo-controlled trial of Lactobacillus GG to prevent diarrhea in undernourished Peruvian children

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.10.1281

Lactobacillus prophylaxis for diarrhea due to enterotoxigenic Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.10.1281

Probiotics and intestinal health effects: a clinical perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.10.1281

Efficacy of Lactobacillus GG as a Diarrheal Preventive in Travelers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.10.1281

Prevention of travellers' diarrhoea by Lactobacillus GG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.10.1281

The role of probiotics and prebiotics in the management of diarrhoea associated with enteral tube feeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.10.1281

Lactobacillus therapy for acute infectious diarrhea in children: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.10.1281

The influence of Lactobacillus brevis on ornithine decarboxylase activity and polyamine profiles in Helicobacter pylori-infected gastric mucosa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.10.1281

Effect of the ingestion of a dietary product containing Lactobacillus johnsonii La1 on Helicobacter pylori colonization in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.10.1281

Effect of whey-based culture supernatant of Lactobacillus acidophilus (johnsonii) La1 on Helicobacter pylori infection in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.10.1281

Favourable effect of an acidified milk (LC-1) on Helicobacter pylori gastritis in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.10.1281

Lack of therapeutic effect of a specially designed yogurt for the eradication of Helicobacter pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.10.1281

Probiotics in the management of atopic eczema

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.10.1281

Probiotics: a novel approach in the management of food allergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.10.1281

Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.10.1281

Effect of preventive administration of a nonpathogenic Escherichia coli strain on the colonization of the intestine with microbial pathogens in newborn infants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.10.1281

Probiotic bacteria in the management of atopic disease: underscoring the importance of viability

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.10.1281

Immunomodulation of human blood cells following the ingestion of lactic acid bacteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.10.1281

Stimulation of the Immune System by Lactic Cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.10.1281

Calcium, phosphorus, vitamin D, dairy products and colorectal carcinogenesis: a French case--control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.10.1281

The role of probiotic bacteria in cancer prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.10.1281

Systemic administration of attenuated Salmonella choleraesuis in combination with cisplatin for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.10.1281

Systemic administration of attenuated Salmonella choleraesuis carrying thrombospondin-1 gene leads to tumor-specific transgene expression, delayed tumor growth and prolonged survival in the murine melanoma model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.10.1281

Treatment of murine colitis by Lactococcus lactis secreting interleukin-10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.10.1281

In situ delivery of cytokines by genetically engineered Lactococcus lactis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.10.1281

Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn's disease: a randomised controlled trial with Lactobacillus GG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.10.1281

Early enteral supply of lactobacillus and fiber versus selective bowel decontamination: a controlled trial in liver transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.10.1281

Probiotics in inflammatory bowel disease: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.10.1281

A review of the role of the gut microflora in irritable bowel syndrome and the effects of probiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.10.1281

A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.10.1281

A controlled, double-blind, randomized study on the efficacy of Lactobacillus plantarum 299V in patients with irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.10.1281

Effect of Lactobacillus plantarum 299v on colonic fermentation and symptoms of irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.10.1281

Effects of a milk product, fermented by Lactobacillus acidophilus and with fructo-oligosaccharides added, on blood lipids in male volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.10.1281

The effect of a probiotic milk product on plasma cholesterol: a meta-analysis of short-term intervention studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.10.1281

Long-term consumption of fermented dairy products over 6 months increases HDL cholesterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.10.1281

Lactobacillus acidophilus as a dietary adjunct for milk to aid lactose digestion in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.10.1281

Influence of nonfermented dairy products containing bacterial starter cultures on lactose maldigestion in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.10.1281

Relationship between lactose digestion, gastrointestinal transit time and symptoms in lactose malabsorbers after dairy consumption.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.10.1281

Hydrogen excretion upon ingestion of dairy products in lactose-intolerant male subjects: importance of the live flora

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.10.1281

Yogurt--an autodigesting source of lactose.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.10.1281

Ingestion of yogurt containing Lactobacillus acidophilus as prophylaxis for candidal vaginitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.10.1281

SEMIPERMEABLE MICROCAPSULES

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.10.1281

Pharmaceutical and therapeutic applications of artificial cells including microencapsulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.10.1281

Therapeutic applications of polymeric artificial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.10.1281

Artificial Cell Therapy: New Strategies for the Therapeutic Delivery of Live Bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.10.1281

Therapeutic uses of microencapsulated genetically engineered cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.10.1281

Mice fed lipid-encapsulated Mycobacterium bovis BCG are protected against aerosol challenge with Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.10.1281

Encapsulated Bifidobacterium bifidum potentiates intestinal IgA production

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.10.1281

Lipase supplementation therapy: standards, alternatives, and perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.10.1281

In vivo and in vitro degradation of urea and uric acid by encapsulated genetically modified microorganisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.10.1281

Reduction of oxaluria after an oral course of lactic acid bacteria at high concentration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.10.1281

Acidified milk formula supplemented with bifidobacterium lactis: impact on infant diarrhea in residential care settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.10.1281

Effect of probiotics on gastrointestinal symptoms and small intestinal permeability in children with atopic dermatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.10.1281

Treatment of perennial allergic rhinitis with lactic acid bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.10.1281

The effect of milk fermented by yogurt cultures plus Lactobacillus casei DN-114001 on the immune response of subjects under academic examination stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.10.1281

Effect of long-term consumption of a probiotic bacterium, Lactobacillus rhamnosus GG, in milk on dental caries and caries risk in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.10.1281

Delay of the first onset of pouchitis by oral intake of the probiotic strain Lactobacillus rhamnosus GG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.10.1281

Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.10.1281

Oral vaccination with Mycobacterium bovis BCG in a lipid formulation induces resistance to pulmonary tuberculosis in brushtail possums

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.10.1281

Oral delivery of Mycobacterium bovis BCG in a lipid formulation induces resistance to pulmonary tuberculosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.10.1281

Oxalobacter formigenes and its potential role in human health.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.10.1281

Evaluation of microencapsulation of a Bifidobacterium strain with starch as an approach to prolonging viability during storage

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.10.1281

Probiotic bacteria: safety, functional and technological properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.10.1281

Encapsulation of probiotic bacteria with alginate-starch and evaluation of survival in simulated gastrointestinal conditions and in yoghurt

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.10.1281

Effects of nonpathogenic bacteria on cytokine secretion by human intestinal mucosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.10.1281

A lyophilized and inactivated culture of Lactobacillus acidophilus increases Helicobacter pylori eradication rates

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.10.1281

10.1517/14712598.5.10.1281

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference